膜性腎症に伴うループ利尿剤抵抗性浮腫と尿蛋白に対し肝腎排泄性アンジオテンシン変換酵素阻害剤(テモカプリル)が奏効した1例

Saved in:
Bibliographic Details
Published in日本腎臓学会誌 Vol. 41; no. 8; pp. 813 - 817
Main Authors 武曾, 恵理, 鎌田, 正, 白川, 喜一, 陶山, 勝郎, 小野, 孝彦, 篠山, 重威, 武田, 敏也, 野垣, 文昭
Format Journal Article
LanguageJapanese
Published 社団法人 日本腎臓学会 25.12.1999
Online AccessGet full text
ISSN0385-2385
1884-0728
DOI10.14842/jpnjnephrol1959.41.813

Cover

Author 野垣, 文昭
鎌田, 正
武田, 敏也
白川, 喜一
陶山, 勝郎
小野, 孝彦
篠山, 重威
武曾, 恵理
Author_xml – sequence: 1
  fullname: 武曾, 恵理
  organization: 京都大学医学研究科循環病態学
– sequence: 1
  fullname: 鎌田, 正
  organization: 京都大学医学研究科循環病態学
– sequence: 1
  fullname: 白川, 喜一
  organization: 京都大学医学研究科循環病態学
– sequence: 1
  fullname: 陶山, 勝郎
  organization: 京都大学医学研究科循環病態学
– sequence: 1
  fullname: 小野, 孝彦
  organization: 京都大学医学研究科循環病態学
– sequence: 1
  fullname: 篠山, 重威
  organization: 京都大学医学研究科循環病態学
– sequence: 1
  fullname: 武田, 敏也
  organization: 京都大学医学研究科循環病態学
– sequence: 1
  fullname: 野垣, 文昭
  organization: 京都大学医学研究科循環病態学
BookMark eNpdkEFLG0EYhoeiYKr-Bq_tYePMzmx29lhCbUXBS-7L7O6kZklj2OTSW3fXxCYRBS-rRGkJEdsG0kIMbalNf8xkN-u_6JAUD17e7-PjfZ8P3qdgqXJQ4QBsIJhFhBJ1061W3Aqv7nsHZWRoRpagLEX4CcggSokCdZUugQzEVFNUKStgvVYrWRBRHWJNJxkwTJuXyfubtHEyi46EP5je3Qq_KcKBCO9EGMUfvsTf_8atftIeJ-1IOpPxMG0MhP9Z3tNuZ3bxR6bibxPhR2lwJTnJyVkyOpROEfREOBLBTxF8FWFzvv-QGvdbyWn3vjGe3X66P_8dD0eS_2zu6IlAPo5EKAOD58I_jq9P4_YvyRb-RzSddNbAcpGVa3z9_1wFha2XhfxrZXfv1Xb-xa7iGipTbMacouHkipDbug5ty8rpFuEcQ8JzDqOOxrRc0WCIImYZGsacQhUZCKvYdojO8CrYWWDdWp294WbVK71l3juTefWSXebmo9ZNgky6EFn-g8veZ57pMvwPOVjBbg
ContentType Journal Article
Copyright 社団法人日本腎臓学会
Copyright_xml – notice: 社団法人日本腎臓学会
DOI 10.14842/jpnjnephrol1959.41.813
DeliveryMethod fulltext_linktorsrc
EISSN 1884-0728
EndPage 817
ExternalDocumentID article_jpnjnephrol1959_41_8_41_8_813_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
OK1
RJT
ID FETCH-LOGICAL-j92a-caadf9d6f0ec770cbb67b4ee304e6da8d5a56f9a181ab9533e802191323cd47a3
ISSN 0385-2385
IngestDate Wed Sep 03 06:06:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 8
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j92a-caadf9d6f0ec770cbb67b4ee304e6da8d5a56f9a181ab9533e802191323cd47a3
OpenAccessLink https://www.jstage.jst.go.jp/article/jpnjnephrol1959/41/8/41_8_813/_article/-char/ja
PageCount 5
ParticipantIDs jstage_primary_article_jpnjnephrol1959_41_8_41_8_813_article_char_ja
PublicationCentury 1900
PublicationDate 1999-12-25
PublicationDateYYYYMMDD 1999-12-25
PublicationDate_xml – month: 12
  year: 1999
  text: 1999-12-25
  day: 25
PublicationDecade 1990
PublicationTitle 日本腎臓学会誌
PublicationTitleAlternate 日腎会誌
PublicationYear 1999
Publisher 社団法人 日本腎臓学会
Publisher_xml – name: 社団法人 日本腎臓学会
References 10. Rostoker G, Maadi A, Remy P, Lang P, Lagrue G, Weil B. Low-dose angiotensin-converting-enzyme inhibitor captoril to reduce proteinuria in adult idiopathic membranous nephropathy : a prospective study of longterm treatment. Nephrol Dial Transplant 1995; 10 : 25-9.
9. Daniel CC, Terry D, Janet R, Edward C, Carl C, Richard C, Susan R. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 1989 ; 320 : 210-5.
6. Iwatsubo H, Nagano M, Sakai T, Kumamoto K, Morita R, Higaki J, Ogihara T, Hata T. Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension. Hypertension 1997 ; 29 : 286-90.
2. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibitor on diabetic nephropathy. N Engl J Med 1993; 329: 1456-62.
7. Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993 ; 329 : 85-9.
11. Monteiro AS, Coimbra TM, Costa RS, Baroni EA. Urinary transforming growth factor -β(TGF-β) excretion and renal production of TGF-β in rats with subtotal renal ablation effect of enalapril and nifedipine. Nephron 1998; 78: 302-9.
3. Kamper AL, Strandgaard S, Leyssac PP. Effect of enalapril on the progression of chronic renal failure. Am J Hypertens 1992; 5: 423-30.
8. Pollak YE. Treatment of membranous glomerulonephritis. Am J Kidney Dis 1992 ; 19 : 68-71.
13. Suzuki H, Kawaratani T, Shioya H, Uji Y, Saruta T. Study on pharmacokinetics of a new biliary excreted oral angiotensin converting enzyme inhibitor, temocapril (CS 622) , in humans. Biopharm Drug Dispos 1993; 14: 41-50.
5. Modena B, Holmer S, Eckardt KU, Schricker K, Riegger G, Kaissling B, Kurtz A. Furosemide stimulates renin expression in the kidneys of saltsupplemented rats. Pflugers Arch 1993; 424: 403-9.
14. Suyama K, Sakurai M, Kawamura T, Kamata T, Oyama A, Muso E, Sasayama S. Specific protective effect on malignant FGS lesion of lipophilic ACE inhibitor (Temocapril) by blocking local renin-angiotensin system (RAS). (abstract) J Am Soc Nephrol 1996 :1747.
1. Myers BD, Nelson RG, Tan M, Beck GJ, Bennett PH, Knowler WC, Blouch K, Mitch WE. Progression of overt nephropathy in non-insulin-dependent diabetes. Kidney Int 1995; 47:1781-9.
4. Hannedouche T, Landais P, Goldfarb B, Esper NE, Fournier A, Godin M, Durand D, Chanard J, Mignon F, Suc JM, Grunfeld JP. Randomized controlled trial of enalapril and β-blockers in non diabetic chronic renal failure. BMJ 1994; 309: 833-7.
12. Largo R, Gomes-Garre D, Sota K, Marron B, Balanco J, Gazapo RM, Plaza JJ, Egido J. Angiotensin converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 1999; 33: 732-9.
15. Koike H, Yanagisawa H, Ikeda T, Manabe S, Ishikawa S, Kawahara T. Temocapril(CS-622), anovel angiotensin converting enzyme inhibitor. Ann Rep Sankyo Res Lab 1992; 44:1-81.
References_xml – reference: 2. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibitor on diabetic nephropathy. N Engl J Med 1993; 329: 1456-62.
– reference: 12. Largo R, Gomes-Garre D, Sota K, Marron B, Balanco J, Gazapo RM, Plaza JJ, Egido J. Angiotensin converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 1999; 33: 732-9.
– reference: 8. Pollak YE. Treatment of membranous glomerulonephritis. Am J Kidney Dis 1992 ; 19 : 68-71.
– reference: 11. Monteiro AS, Coimbra TM, Costa RS, Baroni EA. Urinary transforming growth factor -β(TGF-β) excretion and renal production of TGF-β in rats with subtotal renal ablation effect of enalapril and nifedipine. Nephron 1998; 78: 302-9.
– reference: 3. Kamper AL, Strandgaard S, Leyssac PP. Effect of enalapril on the progression of chronic renal failure. Am J Hypertens 1992; 5: 423-30.
– reference: 9. Daniel CC, Terry D, Janet R, Edward C, Carl C, Richard C, Susan R. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 1989 ; 320 : 210-5.
– reference: 10. Rostoker G, Maadi A, Remy P, Lang P, Lagrue G, Weil B. Low-dose angiotensin-converting-enzyme inhibitor captoril to reduce proteinuria in adult idiopathic membranous nephropathy : a prospective study of longterm treatment. Nephrol Dial Transplant 1995; 10 : 25-9.
– reference: 1. Myers BD, Nelson RG, Tan M, Beck GJ, Bennett PH, Knowler WC, Blouch K, Mitch WE. Progression of overt nephropathy in non-insulin-dependent diabetes. Kidney Int 1995; 47:1781-9.
– reference: 4. Hannedouche T, Landais P, Goldfarb B, Esper NE, Fournier A, Godin M, Durand D, Chanard J, Mignon F, Suc JM, Grunfeld JP. Randomized controlled trial of enalapril and β-blockers in non diabetic chronic renal failure. BMJ 1994; 309: 833-7.
– reference: 7. Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993 ; 329 : 85-9.
– reference: 15. Koike H, Yanagisawa H, Ikeda T, Manabe S, Ishikawa S, Kawahara T. Temocapril(CS-622), anovel angiotensin converting enzyme inhibitor. Ann Rep Sankyo Res Lab 1992; 44:1-81.
– reference: 14. Suyama K, Sakurai M, Kawamura T, Kamata T, Oyama A, Muso E, Sasayama S. Specific protective effect on malignant FGS lesion of lipophilic ACE inhibitor (Temocapril) by blocking local renin-angiotensin system (RAS). (abstract) J Am Soc Nephrol 1996 :1747.
– reference: 5. Modena B, Holmer S, Eckardt KU, Schricker K, Riegger G, Kaissling B, Kurtz A. Furosemide stimulates renin expression in the kidneys of saltsupplemented rats. Pflugers Arch 1993; 424: 403-9.
– reference: 13. Suzuki H, Kawaratani T, Shioya H, Uji Y, Saruta T. Study on pharmacokinetics of a new biliary excreted oral angiotensin converting enzyme inhibitor, temocapril (CS 622) , in humans. Biopharm Drug Dispos 1993; 14: 41-50.
– reference: 6. Iwatsubo H, Nagano M, Sakai T, Kumamoto K, Morita R, Higaki J, Ogihara T, Hata T. Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension. Hypertension 1997 ; 29 : 286-90.
SSID ssib018703574
ssib004261733
ssib058493074
ssib000833381
ssib002004354
ssib005879731
ssib039893136
ssib008531636
ssib038076193
ssj0000696431
ssib000940323
ssib002822005
ssib038586121
ssib047305546
Score 1.5441244
SourceID jstage
SourceType Publisher
StartPage 813
Title 膜性腎症に伴うループ利尿剤抵抗性浮腫と尿蛋白に対し肝腎排泄性アンジオテンシン変換酵素阻害剤(テモカプリル)が奏効した1例
URI https://www.jstage.jst.go.jp/article/jpnjnephrol1959/41/8/41_8_813/_article/-char/ja
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本腎臓学会誌, 1999, Vol.41(8), pp.813-817
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1884-0728
  dateEnd: 20071231
  omitProxy: true
  ssIdentifier: ssj0000696431
  issn: 0385-2385
  databaseCode: KQ8
  dateStart: 19590101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1884-0728
  dateEnd: 20071231
  omitProxy: true
  ssIdentifier: ssib018703574
  issn: 0385-2385
  databaseCode: DIK
  dateStart: 19590101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1NixNJtBG9eJEVldVV8WCBIj32R3V11bE76eAHepoFb6GTdA5BxkHGiyeTOKOOouAliooiiu4OjMI47C6r7o9pk4n_wveqqrvL0cM6CKGpvHpf9V6lql6n6pVlHW37QdfzQ2rjxTg2ZRmzOeumduh30hQzQ3L5HvLceXbqd3rmQnBh245jxq6lKwutmfbV754r2YpXAQZ-xVOyP-DZkikAoAz-hSd4GJ7_y8ck4YQzImokYbhlIQolJCA8IUlIREgg1E98WC2SKCYJJXGNxFRDgBALvqySBahVBSBMgAknkcBC7JC4ISGCRFTKikgc6AIil9IZwqNEq6E5g3Ru8OFExITHUkNB4rqhIZA0SJxoiFDN8YioG-1i-BSelAVo1JDuI3LkFc3xNSTmRVWkq8q2VzihAQmwmdBY5NxAbROB0rHJIRowchAiOImVzommUvbx-GYpWiWvMrUoxJUqQZUnCtfUJNsApSNbsLYwbKIKDVd6NAFTmhEGKg1IkXQP9IyoZtiOY4cQqoV1EjHdJ0SEVaAKL9-ZI7VGYWiBWO6alRZxtSGEQzir8AVKQM2hhqKvNT5y8Su00ukB2hw8K9ECIlQ_pugt7phsEZ9JfBc_Gh86EHYLIQ2dVC-vZMIL17PVQXc53KDQSJoK5cSgju48IpACwbzRia3ZzZhHfR7YsDJVYjM1z3NObSfUeQn0QkBlYNMDHjdmda6OSxcLRHXY-Ju1B-UUkxn35ud6cxmMxJcuYuKmGerOlPRfJXbXw0ZzE0GTuk2uHkDXLLDwEGazB5HgDi9kDO9qqZ8-awZSvm-eqBfU8c3ABv_xNxMnQlyw6Z4KNzQCv4CHeKdd-R0W9RC4lYGLC7O8H1SBI95awdxqpsfdBpiasPwuICxyK3oaYqLB6kUUREHCL7JyqTU05gmU150W3tObc9HKJ79vYwgiehBSF9txZYQw-4u1S4f2RyJlyt3Wtl66x1qdLj2eXHs1Xby7MbqR91c-vX-X95fy4Uo-fJ8PR-Obf4zf_je-9WKyvD5ZHgHmZH11uriS918DfPro9sbDD0A1fvMx74-mgyfAZ3L3_mTtOmDmg-f5cC0f_J0P_syHS7L8FzzHL25N7j36vLi-8e7Z5wf_jlfXgP8xifE8H4DgUT4EgpXjef_O-OW98fI_wDvvP3U_fby915ptJLO1U7a-I8fuCS-122na6YoO6zpZOwyddqvFwhbNMt-hGeukvBOkAeuKFOK4tIUnCTIOQZ1woW_A3Bym_j5r-9yluexX60g35amTddoOy1LKO13eYoxnGRNdCCGp4PuturJuc17lQWpuqQMf-DlsfrN2VuPJQWv7wuUr2SEIDxdah-Uv4wuOvHgy
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%86%9C%E6%80%A7%E8%85%8E%E7%97%87%E3%81%AB%E4%BC%B4%E3%81%86%E3%83%AB%E3%83%BC%E3%83%97%E5%88%A9%E5%B0%BF%E5%89%A4%E6%8A%B5%E6%8A%97%E6%80%A7%E6%B5%AE%E8%85%AB%E3%81%A8%E5%B0%BF%E8%9B%8B%E7%99%BD%E3%81%AB%E5%AF%BE%E3%81%97%E8%82%9D%E8%85%8E%E6%8E%92%E6%B3%84%E6%80%A7%E3%82%A2%E3%83%B3%E3%82%B8%E3%82%AA%E3%83%86%E3%83%B3%E3%82%B7%E3%83%B3%E5%A4%89%E6%8F%9B%E9%85%B5%E7%B4%A0%E9%98%BB%E5%AE%B3%E5%89%A4%28%E3%83%86%E3%83%A2%E3%82%AB%E3%83%97%E3%83%AA%E3%83%AB%29%E3%81%8C%E5%A5%8F%E5%8A%B9%E3%81%97%E3%81%9F1%E4%BE%8B&rft.jtitle=%E6%97%A5%E6%9C%AC%E8%85%8E%E8%87%93%E5%AD%A6%E4%BC%9A%E8%AA%8C&rft.au=%E6%AD%A6%E6%9B%BE%2C+%E6%81%B5%E7%90%86&rft.au=%E9%8E%8C%E7%94%B0%2C+%E6%AD%A3&rft.au=%E7%99%BD%E5%B7%9D%2C+%E5%96%9C%E4%B8%80&rft.au=%E9%99%B6%E5%B1%B1%2C+%E5%8B%9D%E9%83%8E&rft.date=1999-12-25&rft.pub=%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E8%85%8E%E8%87%93%E5%AD%A6%E4%BC%9A&rft.issn=0385-2385&rft.eissn=1884-0728&rft.volume=41&rft.issue=8&rft.spage=813&rft.epage=817&rft_id=info:doi/10.14842%2Fjpnjnephrol1959.41.813&rft.externalDocID=article_jpnjnephrol1959_41_8_41_8_813_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0385-2385&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0385-2385&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0385-2385&client=summon